BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32287069)

  • 1. Frailty transitions, inflammation, and mortality among persons aging with HIV infection and injection drug use.
    Piggott DA; Bandeen-Roche K; Mehta SH; Brown TT; Yang H; Walston JD; Leng SX; Kirk GD
    AIDS; 2020 Jul; 34(8):1217-1225. PubMed ID: 32287069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use.
    Piggott DA; Varadhan R; Mehta SH; Brown TT; Li H; Walston JD; Leng SX; Kirk GD
    J Gerontol A Biol Sci Med Sci; 2015 Dec; 70(12):1542-7. PubMed ID: 26386010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frailty, HIV infection, and mortality in an aging cohort of injection drug users.
    Piggott DA; Muzaale AD; Mehta SH; Brown TT; Patel KV; Leng SX; Kirk GD
    PLoS One; 2013; 8(1):e54910. PubMed ID: 23382997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty and Cause-Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use.
    Piggott DA; Muzaale AD; Varadhan R; Mehta SH; Westergaard RP; Brown TT; Patel KV; Walston JD; Leng SX; Kirk GD
    J Gerontol A Biol Sci Med Sci; 2017 Mar; 72(3):389-394. PubMed ID: 27516622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals.
    Akgün KM; Tate JP; Crothers K; Crystal S; Leaf DA; Womack J; Brown TT; Justice AC; Oursler KK
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):397-404. PubMed ID: 25202921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapy.
    Blanco JR; Romero L; Ramalle-Gómara E; Metola L; Ibarra V; Sanz M; Oteo JA; Garcia A; Pérez-Martínez L
    HIV Med; 2020 Jul; 21(6):358-364. PubMed ID: 31885153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: The Veterans Aging Cohort Study Index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons.
    Escota GV; Patel P; Brooks JT; Bush T; Conley L; Baker J; Kojic EM; Hammer J; Önen NF;
    AIDS Res Hum Retroviruses; 2015 Mar; 31(3):313-7. PubMed ID: 25495766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frailty among HIV-1 Infected Adults under Antiretroviral Therapy in Indonesia.
    Wulunggono W; Yunihastuti E; Shatri H; Wahyudi ER; Ophinni Y
    Curr HIV Res; 2019; 17(3):204-213. PubMed ID: 31456523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
    Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
    HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of transitions in frailty severity and mortality among people aging with HIV.
    Brothers TD; Kirkland S; Theou O; Zona S; Malagoli A; Wallace LMK; Stentarelli C; Mussini C; Falutz J; Guaraldi G; Rockwood K
    PLoS One; 2017; 12(10):e0185352. PubMed ID: 28981535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Circulating Soluble Tumor Necrosis Factor-α Receptors 1 and 2 with Interleukin-6 Levels in an Aging Cohort of Injection Drug Users with or at High Risk for HIV Infection.
    Leng SX; Dandorf S; Li H; Carlson J; Hui J; Mehta SH; Piggott D; Islam S; Manwani B; Kirk GD
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1257-64. PubMed ID: 26414536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation Strikes Again: Frailty and HIV.
    Fukui SM; Piggott DA; Erlandson KM
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):20-29. PubMed ID: 29411315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China.
    Jiang H; Xie N; Cao B; Tan L; Fan Y; Zhang F; Yao Z; Liu L; Nie S
    PLoS One; 2013; 8(12):e83078. PubMed ID: 24376638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frailty transitions in the San Antonio Longitudinal Study of Aging.
    Espinoza SE; Jung I; Hazuda H
    J Am Geriatr Soc; 2012 Apr; 60(4):652-60. PubMed ID: 22316162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative Perception of Aging Is Associated With Frailty Transitions Within a Cohort of Sexual Minority Men.
    Nieves-Lugo K; Ware D; Althoff K; Brennan-Ing M; Meanley S; Brown AL; Haberlen SA; Masters M; Egan JE; Friedman MR; Plankey M
    Innov Aging; 2021; 5(4):igab035. PubMed ID: 34805554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.
    Piggott DA; Erlandson KM; Yarasheski KE
    Curr HIV/AIDS Rep; 2016 Dec; 13(6):340-348. PubMed ID: 27549318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
    Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.